Ashley Glode, Pharm.D., University of Colorado Cancer Center (IMAGE)
Caption
Ashley Glode, Pharm.D., and colleagues present preliminary evidence for lowering dosage or reducing schedule of neoadjuvant chemotherapy for locally advanced rectal cancer.
Credit
University of Colorado Cancer Center
Usage Restrictions
None
License
Licensed content